Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Numark Brands is a consumer healthcare company that specializes in the marketing and distribution of over-the-counter (OTC) pharmaceutical products. Founded in 2011 as a portfolio company of Brynwood Partners, it was created to manage a suite of legacy brands acquired from GlaxoSmithKline. In 2013, the company was acquired by Prestige Consumer Healthcare for $150 million. Its portfolio includes well-known analgesics such as BC Powder and Goody's Headache Powder, as well as Ecotrin and the sleep aid Sominex. The company focuses on maintaining the market presence of established brands through strategic advertising and retail partnerships. It operates as a subsidiary within the broader Prestige Consumer Healthcare organization, contributing to their extensive portfolio of household names.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Numark Brands.